Development of an orally active tripeptide arginal thrombin inhibitor.
| Autor: | Shuman RT; Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana 46285, USA., Gesellchen PD |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Pharmaceutical biotechnology [Pharm Biotechnol] 1998; Vol. 11, pp. 57-80. |
| DOI: | 10.1007/0-306-47384-4_4 |
| Databáze: | MEDLINE |
| Externí odkaz: |
|